Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis

Wiest, 2012, Spontaneous bacterial peritonitis: recent guidelines and beyond, Gut, 61, 297, 10.1136/gutjnl-2011-300779 Scarpellini, 2010, Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?, American Journal of Gastroenterology, 105, 323, 10.1038/ajg.2009.558 Guarner, 1997, Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites, Journal of Hepatology, 26, 1372, 10.1016/S0168-8278(97)80474-6 Chang, 1998, Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis, Hepatology, 28, 1187, 10.1002/hep.510280504 Wiest, 2005, Bacterial translocation (BT) in cirrhosis, Hepatology, 41, 422, 10.1002/hep.20632 Rabinovitz, 1989, Role of serum complement, immunoglobulins, and cell-mediated immune system in the pathogenesis of spontaneous bacterial peritonitis (SBP), Digestive Diseases and Sciences, 34, 1547, 10.1007/BF01537108 Targownik, 2007, The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use, American Journal of Gastroenterology, 102, 942, 10.1111/j.1572-0241.2007.01106.x Garcia-Tsao, 2007, Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis, Hepatology, 46, 922, 10.1002/hep.21907 Norberto, 2008, Use and overuse of proton pump inhibitors in cirrhotic patients, Medical Science Monitor, 9, 468 Jacobs, 2013, Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth, Alimentary Pharmacology and Therapeutics, 37, 1103, 10.1111/apt.12304 Bajaj, 2009, Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites, American Journal of Gastroenterology, 104, 1130, 10.1038/ajg.2009.80 Goel, 2012, Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression, Clinical Gastroenterology and Hepatology, 10, 422, 10.1016/j.cgh.2011.11.019 Deshpande, 2013, Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis, Journal of Gastroenterology and Hepatology, 28, 235, 10.1111/jgh.12065 Trikudanathan, 2011, Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients – a systematic review and meta-analysis, International Journal of Clinical Practice, 65, 674, 10.1111/j.1742-1241.2011.02650.x Min, 2014, Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study, Alimentary Pharmacology and Therapeutics, 40, 695, 10.1111/apt.12875 Mandorfer, 2014, Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites, PLOS ONE, 9, e110503, 10.1371/journal.pone.0110503 Kwon, 2014, Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis, Journal of Gastroenterology and Hepatology, 29, 775, 10.1111/jgh.12426 O’Leary, 2014, Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis, Clinical Gastroenterology and Hepatology, 4 Terg, 2015, Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study, Journal of Hepatology, 5, 1056, 10.1016/j.jhep.2014.11.036 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, British Medical Journal, 339, b2535, 10.1136/bmj.b2535 Stang, 2010, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, European Journal of Epidemiology, 25, 603, 10.1007/s10654-010-9491-z Davies, 1998, When can odds ratios mislead?, British Medical Journal, 316, 989, 10.1136/bmj.316.7136.989 Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Statistics in Medicine, 21, 1539, 10.1002/sim.1186 Higgins, 2003, Measuring inconsistency in meta-analyses, British Medical Journal, 327, 557, 10.1136/bmj.327.7414.557 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, British Medical Journal, 315, 629, 10.1136/bmj.315.7109.629 Higgins, 2011 Campbell, 2008, Association between proton pump inhibitor use and spontaneous bacterial peritonitis, Digestive Diseases and Sciences, 53, 394, 10.1007/s10620-007-9899-9 Northup, 2008, Chronic proton pump inhibitor use is strongly associated with hepatorenal syndrome and spontaneous bacterial peritonitis in cirrhosis patients, Hepatology, 48, 325a Bulsiewicz, 2009, 63 proton pump inhibitor (PPI) use is independently associated with spontaneous bacterial peritonitis (SBP) in cirrhotics with ascites, Gastroenterology, 136, A11, 10.1016/S0016-5085(09)60053-6 Choi, 2011, Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites, Scandinavian Journal of Gastroenterology, 46, 616, 10.3109/00365521.2011.551891 van Vlerken, 2012, Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability, European Journal of Clinical Investigation, 42, 760, 10.1111/j.1365-2362.2011.02643.x Aditi, 2012, Role of proton pump inhibitors in the development of spontaneous bacterial peritonitis amongst cirrhotics; a retrospective cohort study, Gastroenterology, 142, S-946, 10.1016/S0016-5085(12)63667-1 de Vos, 2013, Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites, Liver International, 33, 1316, 10.1111/liv.12210 Miura, 2014, Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis, Internal Medicine, 53, 1037, 10.2169/internalmedicine.53.2021 Ratelle, 2014, Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites, Canadian Journal of Gastroenterology & Hepatology, 28, 330, 10.1155/2014/751921 Mann, 2003, Observational research methods. Research design II: cohort, cross sectional, and case–control studies, Emergency Medicine, J20, 54 Law, 2010, Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS, Digestive Diseases and Sciences, 55, 2302, 10.1007/s10620-009-1010-2 Choung, 2011, Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture, Alimentary Pharmacology and Therapeutics, 33, 1059, 10.1111/j.1365-2036.2011.04625.x Lombardo, 2010, Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy, Clinical Gastroenterology and Hepatology, 8, 504, 10.1016/j.cgh.2009.12.022 Thorens, 1996, Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study, Gut, 39, 54, 10.1136/gut.39.1.54 Naunton, 2000, Overuse of proton pump inhibitors, Journal of Clinical Pharmacy and Therapeutics, 25, 333, 10.1046/j.1365-2710.2000.00312.x Dultz, 2015, Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis, Alimentary Pharmacology and Therapeutics, 41, 459, 10.1111/apt.13061 Lodato, 2008, Proton pump inhibitors in cirrhosis: tradition or evidence based practice?, World Journal of Gastroenterology, 14, 2980, 10.3748/wjg.14.2980 Chavez-Tapia, 2008, Use and overuse of proton pump inhibitors in cirrhotic patients, Medical Science Monitor, 14, CR468